CRISM Therapeutics Corporation
AMMCF
$6.77
$6.573,309.57%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.38M | 4.38M | 7.31M | 7.31M | 3.48M |
| Total Receivables | -- | -- | 469.00K | 469.00K | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 402.00K | 402.00K | -- | -- | 63.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | 25.20M |
| Total Current Assets | 4.79M | 4.79M | 7.78M | 7.78M | 28.74M |
|
|
|||||
| Total Current Assets | 4.79M | 4.79M | 7.78M | 7.78M | 28.74M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 4.79M | 4.79M | 7.78M | 7.78M | 28.74M |
|
|
|||||
| Total Accounts Payable | 471.00K | 471.00K | 377.00K | 377.00K | 131.00K |
| Total Accrued Expenses | 82.00K | 82.00K | 866.00K | 866.00K | 614.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 109.00K | 109.00K | 1.99M | 1.99M | 176.00K |
| Total Other Current Liabilities | 109.00K | 109.00K | 1.99M | 1.99M | 176.00K |
| Total Current Liabilities | 662.00K | 662.00K | 3.24M | 3.24M | 921.00K |
|
|
|||||
| Total Current Liabilities | 662.00K | 662.00K | 3.24M | 3.24M | 921.00K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 662.00K | 662.00K | 3.24M | 3.24M | 921.00K |
|
|
|||||
| Common Stock & APIC | 85.07M | 85.07M | 85.07M | 85.07M | 85.07M |
| Retained Earnings | -80.95M | -80.95M | -81.04M | -81.04M | -40.53M |
| Treasury Stock & Other | -- | -- | 514.00K | 514.00K | -16.72M |
| Total Common Equity | 4.12M | 4.12M | 4.55M | 4.55M | 27.82M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.12M | 4.12M | 4.55M | 4.55M | 27.82M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 4.12M | 4.12M | 4.55M | 4.55M | 27.82M |
|
|
|||||
